Long-term follow-up of the safety of delayed-release dimethyl fumarate in RRMS: interim results from the ENDORSE extension study

被引：0
|
作者：
Pozzilli, C. [1 ]
Phillips, J. T. [2 ]
Fox, R. J. [3 ]
Selmaj, K. [4 ]
Zhang, R. [5 ]
Novas, M. [5 ]
Sweetser, M. T. [5 ]
Gold, R. [6 ]
机构：
[1] Univ Roma La Sapienza, I-00185 Rome, Italy
[2] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[3] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Med Univ Lodz, Lodz, Poland
[5] Biogen Idec Inc, Cambridge, MA USA
[6] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P066
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [41] Seven-year follow-up of the efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis: Integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert J.
    Zhang, Annie
    Taylor, Catherine
    Marantz, Jing
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 156 - 156
  • [42] Seven-year follow-up of the efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis: integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Xiao, J.
    Taylor, C.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 296 - 297
  • [43] Efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis: eight-year follow-up of an integrated analysis of DEFINE, CONFIRM, and ENDORSE
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Yang, L.
    Taylor, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 313 - 314
  • [44] Efficacy of Delayed-release Dimethyl Fumarate at Seven-Year Follow-up in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: Integrated Analysis of DEFINE, CONFIRM and ENDORSE
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert J.
    Xiao, James
    Taylor, Catherine
    NEUROLOGY, 2017, 88
  • [45] Safety and Efficacy of Delayed-release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from Asia-Pacific and Other Countries: Interim Analysis of the APEX Extension Study
    Saida, Takahiko
    Yamamura, Takashi
    Kondo, Takayuki
    Yun, Jang
    Li, Jie
    Forsythe, Beverley
    Sheikh, Sarah, I
    Zhu, Bing
    NEUROLOGY, 2017, 88
  • [46] Association between no evidence of disease activity (NEDA) and long-term clinical efficacy of delayed-release dimethyl fumarate (DMF) in patients with relapsing-remitting multiple sclerosis from the phase 3 study, ENDORSE
    Havrdova, E.
    Gold, R.
    Fox, R. J.
    Giovannoni, G.
    Xiao, J.
    Edwards, M. R.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 256 - 257
  • [47] Safety and Efficacy of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice: Interim Analysis of ESTEEM
    Everage, Nicholas J.
    Prada, Claudia
    Liu, Shifang
    Balashov, Konstantin
    Macdonell, Richard
    Windsheimer, Jorg
    Giles, Kathryn
    NEUROLOGY, 2017, 88
  • [48] Safety and efficacy of delayed-release dimethyl fumarate in multiple sclerosis patients treated in routine medical practice: interim analysis of ESTEEM
    Everage, N. J.
    Jones, C. C.
    Das, R.
    Hanna, J.
    Liu, S.
    Balashov, K.
    Macdonell, R.
    Windsheimer, J.
    Giles, K.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 715 - 716
  • [49] Long-term effect of delayed-release dimethyl fumarate on total disability burden in DEFINE, CONFIRM, and ENDORSE: area under the curve analysis of changes from baseline in expanded disability status scale scores
    Lechner-Scott, J.
    Bar-Or, A.
    Fox, R. J.
    Gold, R.
    Xiao, J.
    Edwards, M. R.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 247 - 248
  • [50] Levetiracetam:: a long-term follow-up study of efficacy and safety
    Bauer, J.
    Ben-Menachem, E.
    Kraemer, G.
    Fryze, W.
    Da Silva, S.
    Kasteleijn-Nolst Trenite, D. G. A.
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (03): : 169 - 176
12345